Colgate-Palmolive shares fall over 2% after Investor Day. What Goldman Sachs and other brokerages are saying
Colgate-Palmolive shares slipped after the company’s Investor Day 2026, as investors weighed higher brand investments against its long-term growth and profitability strategy. While Goldman Sachs retained a Neutral view, Motilal Oswal and Nuvama maintained Buy ratings, citing volume recovery, premiumisation and category expansion as key growth drivers.
Colgate-Palmolive's stock dipped by 2.35% on Tuesday following its Investor Day 2026 presentation. Analysts from various brokerages offered differing opinions on the stock's future performance. Goldman Sachs maintained a Neutral rating, predicting a potential 1% rise from the current price of Rs 1,965. Motilal Oswal upgraded its stance to Buy, projecting a 27% increase to Rs 2,500, while Nuvama also recommended a Buy, with a target price of Rs 2,350 and a potential 22.5% gain.
Nuvama highlighted the company's commitment to expanding the oral care category in India, noting that over 45% of rural and 76% of urban Indians still lack consistent oral hygiene practices. Colgate's management emphasized their focus on driving growth ahead of profitability, with the premium toothpaste segment expanding 2.5 times since 2021 and retail coverage reaching 1.7 million outlets.
Written by urgent.news from The Economic Times - Top News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
